XML 15 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 644,196 $ 373,173
Accounts receivable, net of allowances of approximately $7.0 million and $17.6 million at June 30, 2016 and December 31, 2015 48,407 52,328
Inventory 74,124 64,584
Prepaid expenses and other current assets 22,598 19,995
Current assets held for sale 0 322,837
Total current assets 789,325 832,917
Fixed assets, net 33,484 34,780
Intangible assets, net 628,159 636,220
Goodwill 255,629 289,441
Restricted cash 1,400 1,428
Contingent purchase price from sale of businesses 143,700 0
Other assets 738 730
Total assets 1,852,435 1,795,516
Current liabilities:    
Accounts payable 26,723 36,038
Accrued expenses 95,792 128,558
Current portion of contingent purchase price 28,737 26,800
Convertible senior notes 52,433 255,473
Deferred revenue 16,429 19,863
Current liabilities held for sale 0 67,515
Total current liabilities 220,114 534,247
Contingent purchase price 89,834 96,957
Convertible senior notes 611,489 312,107
Deferred tax liabilities 88,389 89,996
Other liabilities 11,703 13,346
Total liabilities 1,021,529 1,046,653
Equity component of currently redeemable convertible senior notes 2,444 17,089
Stockholders’ equity:    
Preferred stock, $1.00 par value per share, 5,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.001 par value per share, 187,500,000 authorized; 72,636,475 issued and 70,443,493 outstanding at June 30, 2016 and 71,767,371 issued and 69,574,389 outstanding at December 31, 2015 73 72
Additional paid-in capital 1,224,179 1,208,058
Treasury stock, at cost; 2,192,982 shares at June 30, 2016 and December 31, 2015 (50,000) (50,000)
Accumulated deficit (339,874) (429,865)
Accumulated other comprehensive (loss) income (5,414) 3,973
Total The Medicines Company stockholders’ equity 828,964 732,238
Non-controlling interest in joint venture (502) (464)
Total stockholders’ equity 828,462 731,774
Total liabilities and stockholders’ equity $ 1,852,435 $ 1,795,516